Total Payments
$4,597
2024 Payments
$991.59
Companies
36
Transactions
273
Medicare Patients
640
Medicare Billing
$55,516
Payment Breakdown by Category
Food & Beverage$4,572 (99.5%)
Other$25.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,572 | 272 | 99.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $889.58 | 61 | $0 (2024) |
| ABBVIE INC. | $686.65 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $458.80 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $320.78 | 23 | $0 (2023) |
| GlaxoSmithKline, LLC. | $281.87 | 15 | $0 (2024) |
| PFIZER INC. | $241.28 | 15 | $0 (2024) |
| Amgen Inc. | $234.94 | 15 | $0 (2024) |
| Lilly USA, LLC | $231.79 | 15 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $198.69 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $113.67 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $991.59 | 54 | ABBVIE INC. ($219.65) |
| 2023 | $718.17 | 38 | ABBVIE INC. ($204.76) |
| 2022 | $895.74 | 44 | AstraZeneca Pharmaceuticals LP ($218.13) |
| 2021 | $493.75 | 26 | Novo Nordisk Inc ($166.49) |
| 2020 | $129.69 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($48.40) |
| 2019 | $385.27 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($63.96) |
| 2018 | $557.42 | 45 | Novo Nordisk Inc ($124.33) |
| 2017 | $425.77 | 32 | Novo Nordisk Inc ($153.69) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: Insulin Pump | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes Care | ||||||
| 10/01/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.01 | General |
| Category: Insulin Pump | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Inflammation | ||||||
| 08/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PAIN | ||||||
| 08/06/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: VACCINES | ||||||
| 07/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: PAIN | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Obesity | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 134 | 214 | $25,253 | $12,689 |
| 2022 | 4 | 131 | 213 | $28,265 | $15,046 |
| 2021 | 6 | 167 | 260 | $30,853 | $16,785 |
| 2020 | 7 | 208 | 272 | $25,049 | $10,997 |
Total Patients
640
Total Services
959
Medicare Billing
$55,516
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 93 | $15,418 | $6,914 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $3,550 | $3,003 | 84.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 27 | $3,294 | $1,417 | 43.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 26 | $1,912 | $972.72 | 50.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 26 | $858.00 | $247.52 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 17 | $221.00 | $135.38 | 61.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 104 | $17,160 | $8,086 | 47.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $4,402 | $3,803 | 86.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 48 | $5,713 | $2,870 | 50.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 30 | $990.00 | $287.93 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 107 | $17,655 | $8,836 | 50.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $3,692 | $3,250 | 88.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 55 | $6,078 | $2,989 | 49.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 16 | 16 | $1,200 | $1,044 | 87.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 20 | 36 | $1,188 | $349.56 | 29.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $1,040 | $316.60 | 30.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 64 | $10,560 | $3,913 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 62 | $6,696 | $2,398 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 19 | 19 | $2,698 | $2,077 | 77.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 28 | 28 | $1,960 | $1,701 | 86.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 32 | 32 | $1,664 | $507.52 | 30.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 17 | 30 | $990.00 | $289.40 | 29.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 33 | 37 | $481.00 | $110.22 | 22.9% |
About Dr. Timothy Nush, MD
Dr. Timothy Nush, MD is a Family Medicine healthcare provider based in Goshen, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316160328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Nush, MD has received a total of $4,597 in payments from pharmaceutical and medical device companies, with $991.59 received in 2024. These payments were reported across 273 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,572).
As a Medicare-enrolled provider, Nush has provided services to 640 Medicare beneficiaries, totaling 959 services with total Medicare billing of $55,516. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Goshen, IN
- Active Since 04/10/2007
- Last Updated 05/17/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316160328
Products in Payments
- VRAYLAR (Drug) $402.51
- Ozempic (Drug) $287.72
- FARXIGA (Drug) $278.35
- Victoza (Drug) $223.18
- TRINTELLIX (Drug) $204.97
- UBRELVY (Drug) $180.56
- MOUNJARO (Drug) $138.97
- SUNOSI (Drug) $137.86
- RYBELSUS (Drug) $136.69
- Rybelsus (Drug) $128.88
- QULIPTA (Drug) $127.24
- Otezla (Drug) $102.50
- VYVANSE (Drug) $98.03
- AREXVY (Drug) $96.90
- NURTEC ODT (Drug) $94.97
- TRELEGY ELLIPTA (Drug) $90.69
- GVOKE HYPOPEN (Drug) $85.45
- Trintellix (Drug) $83.37
- Prolia (Biological) $79.30
- ENTRESTO (Drug) $77.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goshen
Andrew Hirsch, Do, DO
Family Medicine — Payments: $18,198
Family Medicine $18,198
Dr. Michelle Shelly, Md, MD
Family Medicine — Payments: $10,377
Family Medicine $10,377
Dr. Laura Munkel, M.d, M.D
Family Medicine — Payments: $6,171
Family Medicine $6,171
Lenora Hirschler, M.d, M.D
Family Medicine — Payments: $4,662
Family Medicine $4,662
Dr. Thomas Pechin, M.d, M.D
Family Medicine — Payments: $3,866
Family Medicine $3,866
John Carey, M.d, M.D
Family Medicine — Payments: $3,321
Family Medicine $3,321